help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 73, No. 3 549-554
doi:10.1210/jcem-73-3-549
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PLOSKER, S. M.
Right arrow Articles by JAFFE, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PLOSKER, S. M.
Right arrow Articles by JAFFE, R. B.

Inhibition of Endogenous Catecholamine Synthesis Augments Early Follicular Phase Luteinizing Hormone Secretion*

SHAYNE M. PLOSKER{dagger}, JARON RABINOVICI{ddagger} and ROBERT B. JAFFE

Reproductive Endocrinology Center, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, California 94143

Address requests for reprints to: Robert B. Jaffe, Reproductive Endocrinology Center, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143.

The physiological role of catecholamines, particularly dopamine and norepinephrine, in the regulation of gonadotropin secretion in humans is unclear. We administered the tyrosine hydroxylase inhibitor {alpha}-methyl-p-tyrosine (AMPT, 500 mg at 800 and 1000 h) to five women in the early follicular phase of the menstrual cycle and compared LH secretion patterns to those in five untreated controls. Commencing at 800 h, blood was drawn every 15 min for LH and PRL measurements until 1600 h. AMPT elevated PRL concentrations (mean ± SEM) from a baseline of 14.72 ± 2.51 µg/L to a peak of 102.2 ± 24 µg/L. LH concentrations [21.97 ± 0.56 (AMPT) vs. 13.51 ± 0.16 IU/L (control), P < 0.0001], LH area under the curve [11014 ± 1815 (AMPT) vs. 7009 ± 404 IU·min/L (control), P = 0.05] and LH pulse amplitude [9.99 ± 2.38 (AMPT) vs. 4.03 ± 0.61 IU/L (control), P = 0.04] were all greater in the group in which catecholamine synthesis was inhibited. There was no difference in pulse frequency between the groups (7.4 ± 0.51 vs. 6.6 ± 0.24 pulses/8 h, P > 0.05). We conclude 1) inhibition of endogenous catecholamine synthesis augments LH levels in the early follicular phase, and 2) increased LH secretion during catecholamine synthesis inhibition is due, at least in part, to increased LH pulse amplitude but not increased LH pulse frequency.

* Supported in part by NIH Center Grant HD-11729. These studies were carried out in the General Clinical Research Center, University of California, San Francisco, with funds provided by the Division of Research Resources, 5M01-RR00079, USPHS.

{dagger} R. Samuel McLaughlin Fellow in Reproductive Endocrinology. Current Address: Division of Reproductive Biology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.

{ddagger} Recipient of Fogarty Fellowship TW04258–01.

Received October 9, 1990.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society